| Financial Year |
March 31 2023 |
| Monetary Funds |
65,980,916,266.00 |
| Held-for-trading Financial Assets |
15,626,930,471.00 |
| Notes Receivable |
194,713,938.00 |
| Accounts Receivable |
24,903,547,413.00 |
| Advances to Suppliers |
698,070,046.00 |
| Other Receivables |
840,023,731.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,990,670,110.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,798,926.00 |
| Other Current Assets |
3,484,157,688.00 |
| Total Current Assets |
135,786,323,827.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,110,268.00 |
| Long-term Equity Investment |
12,658,042,162.00 |
| Investment Properties |
1,130,045,287.00 |
| Fixed Assetes |
200,053,569,671.00 |
| Under-construction Projects |
44,170,164,057.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,291,071,642.00 |
| R&D expenses |
-- |
| Goodwill |
672,119,284.00 |
| Long-Term Deferred and Prepaid Expenses |
559,278,664.00 |
| Deferred Income Tax Assets |
76,037,579.00 |
| Other Non-Current Assets |
4,711,429,167.00 |
| Sub-Total of Non-Current Assets |
276,599,108,017.00 |
| Total Assets |
412,385,431,844.00 |
| Short-Term Loans |
3,015,922,868.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
734,773,957.00 |
| Accounts Payable |
30,563,664,825.00 |
| Accounts Received In Advance |
99,826,933.00 |
| Employee Compensation Payable |
2,451,510,940.00 |
| Taxes Payable |
1,405,842,189.00 |
| Interest Payable |
157,241.00 |
| Dividend Payable |
81,332,440.00 |
| Other payables |
18,658,147,778.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,993,720,650.00 |
| Other Current Liabilities |
3,806,602,834.00 |
| Sub-Total of Current Liabilities |
84,744,561,783.00 |
| Long-term Loans |
121,276,885,609.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
224,960,255.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,318,414,704.00 |
| Other Non-Current Liabilities |
2,430,163,529.00 |
| Sub-Total of Non-Current Liabilities |
130,782,236,631.00 |
| Total Liabilities |
215,526,798,414.00 |
| Paid-In Capital(Or Share Stock) |
38,196,363,421.00 |
| Capital Surplus |
55,300,985,471.00 |
| Surplus Reserve |
3,241,063,934.00 |
| LESS:Treasury Stock |
3,508,201,911.00 |
| Undistributed Profits |
36,013,319,971.00 |
| Minority Stockholder's Interest |
64,596,515,658.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
132,262,117,772.00 |
| Owner's Equity（Stockholder's Equity） |
196,858,633,430.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
412,385,431,844.00 |
